SE422202B - Forfarande for framstellning av amidoximderivat - Google Patents

Forfarande for framstellning av amidoximderivat

Info

Publication number
SE422202B
SE422202B SE7500360A SE7500360A SE422202B SE 422202 B SE422202 B SE 422202B SE 7500360 A SE7500360 A SE 7500360A SE 7500360 A SE7500360 A SE 7500360A SE 422202 B SE422202 B SE 422202B
Authority
SE
Sweden
Prior art keywords
procedure
amidoxime derivatives
preparing
preparing amidoxime
derivatives
Prior art date
Application number
SE7500360A
Other languages
English (en)
Other versions
SE7500360L (sv
Inventor
F Binon
P L Eymard
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of SE7500360L publication Critical patent/SE7500360L/xx
Publication of SE422202B publication Critical patent/SE422202B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, ***e
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/12—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines
    • C07C259/14—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines having carbon atoms of hydroxamidine groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/86—Benzo [b] furans; Hydrogenated benzo [b] furans with an oxygen atom directly attached in position 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
SE7500360A 1974-01-15 1975-01-14 Forfarande for framstellning av amidoximderivat SE422202B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7401286A FR2257273B1 (sv) 1974-01-15 1974-01-15

Publications (2)

Publication Number Publication Date
SE7500360L SE7500360L (sv) 1975-07-16
SE422202B true SE422202B (sv) 1982-02-22

Family

ID=9133487

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7500360A SE422202B (sv) 1974-01-15 1975-01-14 Forfarande for framstellning av amidoximderivat

Country Status (23)

Country Link
US (1) US3931240A (sv)
JP (1) JPS541301B2 (sv)
AR (1) AR201414A1 (sv)
AT (1) AT340912B (sv)
BE (1) BE824227A (sv)
CA (1) CA1037960A (sv)
CH (1) CH593245A5 (sv)
DE (1) DE2501122C3 (sv)
DK (1) DK137953B (sv)
ES (1) ES433816A1 (sv)
FI (1) FI63746C (sv)
FR (1) FR2257273B1 (sv)
GB (1) GB1462311A (sv)
HU (1) HU168062B (sv)
IE (1) IE40883B1 (sv)
IT (1) IT1044267B (sv)
NL (1) NL166020C (sv)
NO (1) NO137894C (sv)
OA (1) OA04881A (sv)
SE (1) SE422202B (sv)
SU (1) SU545254A3 (sv)
YU (1) YU36495B (sv)
ZA (1) ZA748105B (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2422630A1 (fr) * 1978-04-14 1979-11-09 Synthelabo Derives de propionamidoxime et leur application en therapeutique
FR2506767A1 (fr) 1981-05-26 1982-12-03 Synthelabo Derives heterocycliques d'amidoximes, leur preparation et leur application en therapeutique
FR2506764A1 (fr) * 1981-05-26 1982-12-03 Synthelabo Derives d'amidoximes, leur preparation et leur application en therapeutique
JPS58131482A (ja) * 1982-01-29 1983-08-05 Matsushita Electric Ind Co Ltd リフト型逆止弁
US4806663A (en) * 1987-04-06 1989-02-21 The University Of Tennessee Research Corporation Certain 3-substituted 2-alkyl benzofuran derivatives
US4851554A (en) * 1987-04-06 1989-07-25 University Of Tennessee Research Corporation Certain 3-substituted 2-alkyl benzofuran derivatives
US4831156A (en) * 1987-09-30 1989-05-16 The University Of Tennessee Research Corp. 3-substituted 2-alkyl indole derivatives
CN1430603A (zh) * 2000-04-28 2003-07-16 旭化成株式会社 新型双环化合物

Also Published As

Publication number Publication date
NO137894B (no) 1978-02-06
BE824227A (fr) 1975-07-09
DE2501122A1 (de) 1975-07-17
NL7500399A (nl) 1975-07-17
DE2501122B2 (de) 1981-05-21
FR2257273B1 (sv) 1978-01-13
JPS50101348A (sv) 1975-08-11
AU7665374A (en) 1976-06-24
IT1044267B (it) 1980-03-20
IE40883L (en) 1975-07-15
DK137953B (da) 1978-06-12
ATA26875A (de) 1977-05-15
OA04881A (fr) 1980-10-31
US3931240A (en) 1976-01-06
FI63746B (fi) 1983-04-29
AR201414A1 (es) 1975-03-07
DK645174A (sv) 1975-09-08
AT340912B (de) 1978-01-10
FR2257273A1 (sv) 1975-08-08
FI353674A (sv) 1975-07-16
NL166020C (nl) 1981-06-15
CH593245A5 (sv) 1977-11-30
JPS541301B2 (sv) 1979-01-23
SE7500360L (sv) 1975-07-16
GB1462311A (en) 1977-01-26
ES433816A1 (es) 1976-09-16
CA1037960A (en) 1978-09-05
YU349874A (en) 1982-02-25
DE2501122C3 (de) 1982-03-18
FI63746C (fi) 1983-08-10
NO137894C (no) 1978-05-24
ZA748105B (en) 1976-01-28
YU36495B (en) 1984-02-29
IE40883B1 (en) 1979-09-12
SU545254A3 (ru) 1977-01-30
NL166020B (nl) 1981-01-15
DK137953C (sv) 1978-12-18
HU168062B (sv) 1976-02-28
NO750104L (sv) 1975-08-11

Similar Documents

Publication Publication Date Title
SE428562C (sv) Forfarande for framstellning av purinderivat
SE423633B (sv) Forfarande for framstellning av 4-demetoxi-daunomycin
SE420199B (sv) Forfarande for framstellning av 16-oxiderade prostansyraderivat
SE421919B (sv) Forfarande for framstellning av 2-tetrahydrofurfuryl-6,7-bensomorfaner
SE420727B (sv) Analogiforfarande for framstellning av bispidin- och bispidonderivat
SE431652B (sv) Forfarande for framstellning av 7beta-amino-3cefem-3ol-4-karboxylsyraderivat
SE412066B (sv) Forfarande for framstellning av famakologiskt verksamma tienodiazinderivat
SE431211B (sv) Forfarande for framstellning av n-acylamino-alfa-arylacetamido-cefalosporiner
SE7508074L (sv) Forfarande for framstellning av stilbenderivat.
SE421612B (sv) Forfarande for framstellning av alfa-6-deoxi-5-hydroxitetracyklin
SE421921B (sv) Analogiforfarande for framstellning av pyridobensodiazepinoner
SE7506237L (sv) Forfarande for framstellning av dekahydroisokinolinderivat
SE418292B (sv) Forfarande for framstellning av 5-aryl-2-furamidiner
SE422052B (sv) Forfarande for framstellning av vissa angivna 1-fenoxi-2-hydroxi-3-aminofenyl-propylderivat
SE425739B (sv) Forfarande for framstellning av vissa angivna tetrazolyl-bensopyranopyridinderivat
SE422202B (sv) Forfarande for framstellning av amidoximderivat
SE400960B (sv) Forfarande for framstellning av alhŸ3 (poŸ4)Ÿ2 3hŸ2o
SE414926B (sv) Forfarande for framstellning av 1-alkyl-2-(fenoximetyl)-5-nitroimidazoler
SE422210B (sv) Analogiforfarande for framstellning av substituerade indoler
SE415658B (sv) Analogiforfarande for framstellning av linnolinderivat
SE7513739L (sv) Forfarande for framstellning av 2-scyl-4-oxo-pyrazino-isokonolin-derivat
SE404364B (sv) Forfarande for framstellning av vissa angivna 5-sulfonylfenyl-tetrazolderivat
SE425784B (sv) Analogiforfarande for framstellning av eburnameninderivat
SE388854B (sv) Forfarande for framstellning av fenylpyridylaminderivat
SE7506196L (sv) Forfarande for framstellning av amidin-hydrazon-derivat

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7500360-8

Effective date: 19880915

Format of ref document f/p: F